pta20260203027
Public disclosure of inside information according to article 17 MAR
Schlagwоrt(e): Results / Full Year

SYZYGY AG: Preliminary figures confirm expected decline in revenues in 2025

restructuring expenses and future investments weigh on earnings

Bad Hoburg (pta027/03.02.2026/18:25 UTC+1)

  • Net sales of EUR 57 million (-18% compared to the previous year)
  • Operating result (before goodwill impairments) of EUR -1.2 million, corresponding to an operating EBIT margin of -2 per cent
  • Positive operating cash flow of around EUR 5.2 million
  • Core market Germany: Net sales of EUR 46 million (-18% compared to the previous year) with an operating EBIT margin of 4 per cent
  • UK and US segment: Net sales of EUR 5 million (unchanged compared to the previous year) with an operating EBIT margin of -7 per cent
  • Poland segment: Net sales of EUR 6 million (-22% compared to the previous year) with an EBIT margin of 2 per cent
  • Goodwill impairments amounting to EUR 4.7 million
  • Net income of EUR -5.7 million; earnings per share of EUR -0.42
  • Outlook 2026: Net Sales of around EUR 50 million with an EBIT margin of 3-4 per cent

According to preliminary figures, SYZYGY AG generated net sales of EUR 57 million in the 2025 financial year. The 18 per cent decline in sales was in line with expectations. The operating result before goodwill impairments was negative at EUR -1.2 million. Earnings were burdened by additional restructuring expenses of EUR 0.5 million incurred in the fourth quarter. Accordingly, the operating margin amounted to -2 per cent (previous year: 9 per cent).

Operating cash flow remained positive at approximately EUR 5.2 million. Bank liabilities were fully repaid. As of 31 December 2025, the equity ratio stood at approximately 40 per cent.

In the core market of Germany, net sales declined by 18 per cent to EUR 46.1 million, with an operating margin of 4 per cent. Germany accounted for 80 per cent of total group sales.

In the UK and the US, net sales remained at the prior-year level of EUR 5.1 million, while the operating margin amounted to -7 per cent. In Poland, net sales decreased by 22 per cent compared to the previous year to EUR 6.4 million, with an operating margin of 2 per cent.

Due to the persistently challenging market environment, goodwill impairments totaling EUR 4.7 million were recognized, resulting in an EBIT (including goodwill impairments) of EUR -5.9 million. Net financial income for the reporting period was negative at EUR -0.4 million, leading to a group net loss after taxes of around EUR -5.7 million. Earnings per share amounted to around EUR -0.42.

In TEUR20252024Veränd.
Net sales56,83869,429-18 %

Operating result

(EBIT before goodwill inpairment)

-1,1725,666n.a.
EBIT margin (operational)-2.1 %8.2 %-10.3 pp
Impairment of goodwill-4,698-16,643n.a.
EBIT (incl. goodwill inpairment)-5,871-10,977n.a.

EBIT margin

(incl. goodwill inpairment)

-10.3%-15.8%+5.5 pp
Financial income-448-60125%
Profit before taxes-6,319-11,578n.a.
Net income -5,700-13,159n.a.
Operating cash flow5,1889,634-46 %
Earnings per share (EUR)-0.42-0.99n.a.

The full annual report for 2025 will be available from March 31, 2026 at www.syzygy-group.net/investors.

Outlook 2026

SYZYGY is making targeted investments in the development of AI-driven services and client solutions.

CEO Frank Wolfram emphasizes: "2026 marks the transition from proof-of-concept to proof-of-value for AI in enterprise applications. Our AI services and client solutions secure our competitiveness and open up new market opportunities."

Despite a persistently challenging economic and geopolitical environment, SYZYGY expects revenues to stabilize at a lower level. The restructuring measures implemented in 2025 are expected to enable a return to profitability in the current financial year.

For the 2026 financial year, the SYZYGY Group anticipates sales of around EUR 50 million with an EBIT margin of 3 to 4 per cent.

(end)

Emitter: SYZYGY AG
Horexstraße 28
61352 Bad Homburg
Germany
Contact Person: Susan Wallenborn
Phone: +49 (0)6172 9488 252
E-Mail: susan.wallenborn@syzygy-group.net
Website: www.syzygy-group.net
ISIN(s): DE0005104806 (Share)
Stock Exchange(s): Regulated Market in Frankfurt; Free Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX
|